Home/Filings/4/0001209191-15-010377
4//SEC Filing

SOPHIRIS BIO INC. 4

Accession 0001209191-15-010377

CIK 0001563855operating

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 4:45 PM ET

Size

5.4 KB

Accession

0001209191-15-010377

Insider Transaction Report

Form 4
Period: 2015-02-05
HULME ALLISON
Chief Operating Officer
Transactions
  • Award

    Common Stock (Right to Buy)

    2015-02-05+45,48145,481 total
    Exercise: $0.46From: 2016-02-05Exp: 2020-02-04Common Stock (45,481 underlying)
Footnotes (1)
  • [F1]33% of the shares subject to the option shall vest one year after the date of grant. The remainder shall vest monthly thereafter over the next two years until fully vested on February 05, 2018.

Issuer

SOPHIRIS BIO INC.

CIK 0001563855

Entity typeoperating
IncorporatedBritish Columbia, Canada

Related Parties

1
  • filerCIK 0001563855

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:45 PM ET
Size
5.4 KB